Compare NSPR & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NSPR | IAE |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.8M | 80.3M |
| IPO Year | N/A | N/A |
| Metric | NSPR | IAE |
|---|---|---|
| Price | $1.93 | $7.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 101.5K | 46.3K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,779,000.00 | N/A |
| Revenue This Year | $22.76 | N/A |
| Revenue Next Year | $75.45 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.04 | N/A |
| 52 Week Low | $1.59 | $5.31 |
| 52 Week High | $3.80 | $6.45 |
| Indicator | NSPR | IAE |
|---|---|---|
| Relative Strength Index (RSI) | 48.80 | 47.16 |
| Support Level | $1.74 | $7.20 |
| Resistance Level | $2.00 | $7.35 |
| Average True Range (ATR) | 0.12 | 0.11 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 53.85 | 49.30 |
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.